Effects of strengthening exercises addition on task-specific gait training after stroke: a randomised controlled trial

Not Applicable

• Conditions: Hemiplegia; Stroke - Ischaemic; Stroke - Haemorrhagic

• Registration Number: ACTRN12609000803291
• Lead Sponsor: niversidade Federal de Minas Gerais

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-09-16
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Stroke patients will be eligible if they had clinical diagnosis of a first stroke resulting walking deficit; they are living at home for less than 6 months having been discharged from hospital post stroke; they are older than 20 years of age; they are diagnosed clinically with hemiparesis or hemiplegia; they can walk 10 metres independently using aids or orthoses, with or without supervision, their walking velocity is within 0.4 to 0.8 m/s (limited community)

Exclusion Criteria

They will be excluded if they have severe cognitive deficits assessed by the Mini-Mental State Exam and/or language problems (comprehensive aphasia), evaluated by simple motor commands, which could prevent them from following instructions during measurement and/or intervention; they have adverse health conditions, which could affect balance and mobility, such as vestibular disturbances, severe arthritis or other neurological disorders.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ower limb muscle strength. Strength of all 12 lower limb muscles will be measured using hand-held dynamometry.[At baseline,10 weeks after randomisation; 4 weeks after treatment cessation.];Lower limb motor coordination. Motor coordination will be measured using the Lower Extremity Motor Coordination Test (LEMOCOT). It consists of moving the lower extremity as fast as possible from 1 target to another for 20 seconds.[At baseline, 10 weeks after randomisation; 4 weeks after treatment cessation.];Walking ability.<br>Walking ability will be quantified by parameters such as speed (m/s), step length (m), and cadence (steps/min).[At baseline, 10 weeks after randomisation; 4 weeks after treatment cessation.]

Secondary Outcome Measures

Name	Time	Method
Quality of life.<br>The Stroke Specific Quality of Life Scale (SS-QOL)(39) will be used to measure participation. It consists of a single stroke outcome measure that assesses the various domains important in determining stroke-specific health related quality of life across the spectrum of stroke symptoms and severity.[At baseline, 10 weeks after randomisation; 4 weeks after treatment cessation.];Minimal clinically important difference (MCID) of 3 outcome measures (lower limb strength, motor coordination and gait speed) will be estimated using the method of patient?s global ratings of change.[10 weeks after randomisation]